In The News
DEMONS FROM THE SHADOWS - Nitazenes, Cartel Chemists, and the Darkest Possible End of the Drug War
In the first piece, I argued that the United States is losing a chemical war with China, and that the only asymmetric counter-strategy with any historical precedent for success is domesticating the drug supply — legalizing the agrarian, organic substances that humans have used for millennia, regulating them intelligently, and stripping the cartels of their customer base through market competition.
Building Inside Maryland’s Limited License Cannabis Market
Strategy, Scale, and Survival in a Maturing Adult-Use Market
The post Building Inside Maryland’s Limited License Cannabis Market appeared first on Cannabis Industry Journal.
NIH Releases Scientific Paper on the Therapeutic Value of Acidic Cannabinoids
Discussions on the overlooked potential of these powerful compounds are on the rise
The post NIH Releases Scientific Paper on the Therapeutic Value of Acidic Cannabinoids appeared first on Cannabis Industry Journal.
Yale Scientists Reveal The Surprising Mental Health Benefits of Psychedelic Mushrooms
Yale University is one of the pioneering institutions in psilocybin research. So much so that they have their own multidisciplinary program dedicated to studying the effects of psychedelic agents and their therapeutic potential. They are currently running several psilocybin clinical trials, to better learn about its effects on various aspects of mental health, including obsessive-compulsive disorder, major depressive disorder, post-traumatic headaches, and cluster headaches,among others.